An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis
Ayano Fukushima‐Nomura(Keio University), Masayuki Amagai(RIKEN Center for Integrative Medical Sciences), Keiji Tanese(Toho University), Hidehisa Saeki(Nippon Medical School), Takehiro Hasegawa(Sysmex (Germany)), Eiryo Kawakami(Chiba University), Jun Seita(RIKEN Center for Advanced Intelligence Project), Takafumi Etoh(Tokyo Teishin Hospital), Tamotsu Ebihara(Keio University Hospital), Hiroshi Kawasaki(Keio University Hospital), Aiko Sekita(RIKEN Center for Integrative Medical Sciences), Kazuhiro Sakurada(Keio University), Osamu Ohara(Kazusa DNA Research Institute), Koichi Ashizaki(Keio University), Shoko Obata(Keio University), Haruhiko Koseki(Japan Science and Technology Agency), Junshi Yazaki(RIKEN Center for Integrative Medical Sciences), Tomohiro Miyai(RIKEN Center for Integrative Medical Sciences), Kiyoshi Yashiro(Keio University)
Cited by 18
Related Papers
Inflammation-free, gas-permeable, lightweight, stretchable on-skin electronics with nanomeshes
|Nature Nanotechnology|2017|1.1k
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
|British Journal of Dermatology|2020|590
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|588
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586